4157 participants visited the forum organized by the National Research Institution of Oncology last week to discuss issues of epidemiology, screening and prevention of cancer.
While pharmaceutical companies presented on the latest drugs and formulations, leading investigators were interested to learn more about latest trends in clinical research. Many of PIs that attended the forum have immense experience in clinical research and participated in international multicentre trials manages by GCT. Russian clinical sites are fully equipped and qualified to conduct clinical trials in various oncology indication.
Irina Ryzhkova, Deputy Director Legal Affairs at GCT-Russia spoke on «Protecting Investigators’ Rights» topic, which triggered heated debates among participants at the round-table discussions that followed. Irina identified parties that investigators interact during their work (Sponsors, CROs, sites, patients and regulatory authorities), typical reasons for raising a claim, and the ways how the rights of investigators can be protected.
Interested to learn more? Please contact us by email@example.com